Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
96
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Role and Significance of Wnt5a in Regulating Epithelial–Mesenchymal Transition in Endometrioid Adenocarcinoma

Ningning Yang1 Department of Pathology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, People’s Republic of China;2 Department of Pathology, Bengbu Medical College, Bengbu, 233000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0691-7293
ORCID Icon,
Hongchun Chen1 Department of Pathology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, People’s Republic of China;2 Department of Pathology, Bengbu Medical College, Bengbu, 233000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-7751-5390
ORCID Icon,
Yuchen Huang1 Department of Pathology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, People’s Republic of China;2 Department of Pathology, Bengbu Medical College, Bengbu, 233000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-7740-5634
ORCID Icon,
Xuexue Song3 Department of Pathology, First Affiliated Hospital of University of Science and Technology of China, Hefei, 230000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5570-1806
ORCID Icon,
Panpan Yang4 Department of Pathology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3633-6844
ORCID Icon,
Shan Zhang5 Department of Pathology, Second People’s Hospital of Hefei, Hefei, 230000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7891-6906
ORCID Icon,
Wentian Yan1 Department of Pathology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, People’s Republic of China;2 Department of Pathology, Bengbu Medical College, Bengbu, 233000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5260-4701
ORCID Icon,
Nan Li1 Department of Pathology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, People’s Republic of China;2 Department of Pathology, Bengbu Medical College, Bengbu, 233000, People’s Republic of China
&
Zhenzhong Feng1 Department of Pathology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, People’s Republic of China;2 Department of Pathology, Bengbu Medical College, Bengbu, 233000, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-9385-3157
ORCID Icon show all
Pages 6527-6535 | Published online: 20 Aug 2021

References

  • BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • HusseinYR, SoslowRA. Molecular insights into the classification of high-grade endometrial carcinoma. Pathology. 2018;50(2):151–161. doi:10.1016/j.pathol.2017.09.01029246451
  • Clark CC, Cohen I, Eichstetter I, et al. Molecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14-p21. Genomics. 1993;18(2):249–260. doi:10.1006/geno.1993.1463
  • OishiI, SuzukiH, OnishiN, et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells. 2003;8(7):645–654. doi:10.1046/j.1365-2443.2003.00662.x12839624
  • TopolL, JiangX, ChoiH, Garrett-BealL, CarolanPJ, YangY. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol. 2003;162(5):899–908. doi:10.1083/jcb.20030315812952940
  • AsemMS, BuechlerS, WatesRB, MillerDL, StackMS. Wnt5a signaling in cancer. Cancers. 2016;8(9):79–96. doi:10.3390/cancers8090079
  • TaoJ, ShiL, HuangL, et al. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line. J Cancer Res Clin Oncol. 2017;143(11):2211–2219. doi:10.1007/s00432-017-2479-228748258
  • KurayoshiM, OueN, YamamotoH, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res. 2006;66(21):10439–10448. doi:10.1158/0008-5472.CAN-06-235917079465
  • KremenevskajaN, von WasielewskiR, RaoAS, SchöflC, AnderssonT, BrabantG. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene. 2005;24(13):2144–2154. doi:10.1038/sj.onc.120837015735754
  • ZengR, HuangJ, ZhongMZ, et al. Multiple roles of WNT5A in breast cancer. Med Sci Monit. 2016;22:5058–5067. doi:10.12659/MSM.90202228005837
  • DejmekJ, DejmekA, SäfholmA, SjölanderA, AnderssonT. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res. 2005;65(20):9142–9146. doi:10.1158/0008-5472.CAN-05-171016230369
  • BakkerER, DasAM, HelvensteijnW, et al. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice. Carcinogenesis. 2013;34(11):2629–2638. doi:10.1093/carcin/bgt21523764752
  • ScanlonCS, Van TubergenEA, InglehartRC, D’SilvaNJ. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res. 2013;92(2):114–121. doi:10.1177/002203451246735223128109
  • KimS, XuX, HechtA, BoyerTG. Mediator is a transducer of Wnt/beta-catenin signaling. J Biol Chem. 2006;281(20):14066–14075. doi:10.1074/jbc.M60269620016565090
  • BaldusSE, MönigSP, HuxelS, et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res. 2004;10(8):2790–2796. doi:10.1158/1078-0432.CCR-03-016315102686
  • YangAD, FanF, CampER, et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006;12(14):4147–4153. doi:10.1158/1078-0432.CCR-06-003816857785
  • CarvalhoJ, van GriekenNC, PereiraPM, et al. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228(1):31–44.22450781
  • WeigeltB, GeyerFC, NatrajanR, et al. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol. 2010;220(1):45–57. doi:10.1002/path.262919877120
  • XingX, TangYB, YuanG, et al. The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int J Cancer. 2013;132(11):2589–2596. doi:10.1002/ijc.2794723169395
  • KleerCG, CaoQ, VaramballyS, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A. 2003;100(20):11606–11611. doi:10.1073/pnas.193374410014500907
  • ToniniT, BagellaL, D’AndrilliG, ClaudioPP, GiordanoA. Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A. Oncogene. 2004;23(28):4930–4937. doi:10.1038/sj.onc.120760815077161

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.